[go: up one dir, main page]

Avichezer et al., 2003 - Google Patents

An immunologically privileged retinal antigen elicits tolerance: major role for central selection mechanisms

Avichezer et al., 2003

View PDF
Document ID
6232131886757466813
Author
Avichezer D
Grajewski R
Chan C
Mattapallil M
Silver P
Raber J
Liou G
Wiggert B
Lewis G
Donoso L
Caspi R
Publication year
Publication venue
The Journal of experimental medicine

External Links

Snippet

Immunologically privileged retinal antigens can serve as targets of experimental autoimmune uveitis (EAU), a model for human uveitis. The tolerance status of susceptible strains, whose target antigen is not expressed in the thymus at detectable levels, is unclear …
Continue reading at pmc.ncbi.nlm.nih.gov (PDF) (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047Cells of the immune system
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/564Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515Animal cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602Vertebrate cells

Similar Documents

Publication Publication Date Title
Avichezer et al. An immunologically privileged retinal antigen elicits tolerance: major role for central selection mechanisms
Fu et al. Deficiency in T follicular regulatory cells promotes autoimmunity
Chen et al. Where CD4+ CD25+ T reg cells impinge on autoimmune diabetes
Smith et al. Pancreatic gene expression in rare cells of thymic medulla: evidence for functional contribution to T cell tolerance.
Caspi A look at autoimmunity and inflammation in the eye
DeVoss et al. Spontaneous autoimmunity prevented by thymic expression of a single self-antigen
Roep et al. Immune modulation in humans: implications for type 1 diabetes mellitus
Chen et al. Inability of memory T cells to induce graft-versus-host disease is a result of an abortive alloresponse
Huseby et al. Age-dependent T cell tolerance and autoimmunity to myelin basic protein
Zhu et al. Aire deficiency promotes TRP-1–specific immune rejection of melanoma
Hayashi Dysfunction of Lacrimal and Salivary Glands in Sjögren′ s Syndrome: Nonimmunologic Injury in Preinflammatory Phase and Mouse Model
Tuncel et al. T cell anergy in perinatal mice is promoted by T reg cells and prevented by IL-33
Esposito et al. IL-17–and IFN-γ–secreting Foxp3+ T cells infiltrate the target tissue in experimental autoimmunity
Afzali et al. B cells orchestrate tolerance to the neuromyelitis optica autoantigen AQP4
Hoehlig et al. Activation of CD 4+ F oxp3+ regulatory T cells proceeds normally in the absence of B cells during EAE
Mencarelli et al. Calcineurin-mediated IL-2 production by CD11chighMHCII+ myeloid cells is crucial for intestinal immune homeostasis
Lambe et al. Limited peripheral T cell anergy predisposes to retinal autoimmunity
Hässler et al. Aire-deficient mice develop hematopoetic irregularities and marginal zone B-cell lymphoma
Proekt et al. LYN-and AIRE-mediated tolerance checkpoint defects synergize to trigger organ-specific autoimmunity
Taylor et al. Enhanced tolerance to autoimmune uveitis in CD200-deficient mice correlates with a pronounced Th2 switch in response to antigen challenge
van der Touw et al. NK cells are required for costimulatory blockade induced tolerance to vascularized allografts
Malkiel et al. Autoimmune myocarditis does not require B cells for antigen presentation
Thayer et al. Peripheral proinsulin expression controls low-avidity proinsulin-reactive CD8 T cells in type 1 diabetes
Ye et al. TAM receptor knockout mice are susceptible to retinal autoimmune induction
Xu et al. Regulated tristetraprolin overexpression dampens the development and pathogenesis of experimental autoimmune uveitis